The mechanisms of resistance to quinolone and epidemiological relationships among A. salmonicida strains isolated from diseased fish in French marine farms from 1998 to 2000 were investigated. The quinolone resistance-determining regions of the gyrA and parC genes of 12 clinical A. salmonicida isolates with different levels of quinolone susceptibility were sequenced. MICs were determined in the presence of the efflux pump inhibitor (EPI) Phe-Arg β-naphthylamide and Emax values (MIC without EPI/MIC in the presence of EPI) were calculated. Isolates fell into two classes: (i) those that had a wild-type gyrA gene with oxolinic acid MIC ⩽ 0.5, flumequine MIC ⩽ 1 and ciprofloxacin MIC ⩽ 0.25 μg ml−1; and (ii) those that had a single mutation in gyrA encoding Asp-87 → Asn with oxolinic acid MIC ⩾ 2, flumequine MIC ⩾ 4 and ciprofloxacin MIC ⩾ 0.125 μg ml−1. No mutations were found in parC. High Emax values obtained for flumequine and oxolinic acid (up to 16 and 8, respectively, for the most resistant isolates of the two classes) indicated an important contribution of efflux to the resistance phenotype. Flumequine accumulation experiments confirmed that high Emax values were associated with a much lower level of accumulation. PCR/RFLP assays conducted on 34 additional isolates showed the presence of a mutation at codon 87 of gyrA in nearly all the quinolone-resistant isolates. This finding, together with PFGE typing results, strongly suggests a common clonal origin of these quinolone-resistant isolates.
AkasakaT.,
TanakaM.,
YamaguchiA.,
SatoK.2001; Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 45:2263–2268[CrossRef]
BachoualR.,
TankovicJ.,
SoussyC. J.1998; Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli
. Microb Drug Resist 4:271–276[CrossRef]
BagelS.,
HullenV.,
WiedemannB.,
HeisigP.1999; Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli
. Antimicrob Agents Chemother 43:868–875
BlancG.,
Donnay-MorenoC.,
GiraudE.,
GaniereJ. P.2002Antibiorésistance et efficacité thérapeutique des traitements antimicrobiens en pisciculture marine . Report of studies no. 99.16369 and no. 00.5071 pp 1–45 ENV Nantes (in French
CEFAS1999Report of the Concerted Action Workshop on Development of Standard Reference Methods for Antimicrobial Agent Susceptibility Testing for Bacterial Fish Pathogens Weymouth, UK: Centre for Environment, Fisheries and Aquaculture Science;
ChomaratM.,
Guérin-FaubléeV.,
KodjoA.,
BreysseF.,
FlandroisJ. P.1998; Molecular analysis of the fish pathogen Aeromonas salmonicida subsp. salmonicida by pulsed-field electrophoresis. Rev Med Vet 149:245–250
DeguchiT.,
FukuokaA.,
YasudaM. & 7 other authors; 1997; Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae
. Antimicrob Agents Chemother 41:699–701
ErvikA.,
ThorsenB.,
EriksenV.,
LunestadB. T.,
SamuelsenO. B.1994; Impact of administering antibacterial agents on wild fish and blue mussels Mytilus edulis in the vicinity of fish farms. Dis Aquat Org 18:45–51[CrossRef]
FAO2002; Résidus d'antibiotiques dans les produits d'aquaculture. In La Situation Mondiale des Pêches et de l'Aquaculture
. Rome: Food & Agriculture Organization of the United Nations (in French
GarciaJ. A.,
LarsenJ. L.,
DalsgaardI.,
PedersenK.2000; Pulsed-field gel electrophoresis analysis of Aeromonas salmonicida ssp. salmonicida
. FEMS Microbiol Lett 190:163–166[CrossRef]
GibreelA.,
SjogrenE.,
KaijserB.,
WretlindB.,
SkoldO.1998; Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC
. Antimicrob Agents Chemother 42:3276–3278
GiraudE.,
BrisaboisA.,
MartelJ. L.,
Chaslus-DanclaE.1999; Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp.suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43:2131–2137
Goni-UrrizaM.,
ArpinC.,
CapdepuyM.,
DuboisV.,
CaumetteP.,
QuentinC.2002; Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae , A.hydrophila , and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob Agents Chemother 46:350–359[CrossRef]
GrantA. N.,
LaidlerL. A.1993; Assessment of the antimicrobial sensitivity of Aeromonas salmonicida isolates from farmed Atlantic salmon in Scotland. Vet Rec 133:389–391[CrossRef]
GuardabassiL.,
DalsgaardA.,
RaffatelluM.,
OlsenJ. E.2000; Increase in the prevalence of oxolinic acid resistant Acinetobacter spp.observed in a stream receiving the effluent from a freshwater trout farm following the treatment with oxolinic acid-medicated feed. Aquaculture 188:205–218[CrossRef]
HaliassosA.,
ChomelJ. C.,
TessonL.,
BaudisM.,
KruhJ.,
KaplanJ. C.,
KitzisA.1989; Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17:3606[CrossRef]
InglisV.,
RichardsR. H.1991; The in vitro susceptibility of Aeromonas salmonicida and other fish-pathogenic bacteria to 29 antimicrobial agents. J Fish Dis 14:641–650[CrossRef]
MartinsenB.,
HorsbergT. E.1995; Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon ( Salmo salar ) held in seawater at 10 degrees C. Antimicrob Agents Chemother 39:1059–1064[CrossRef]
OppegaardH.,
SorumH.1994; gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida
. Antimicrob Agents Chemother 38:2460–2464[CrossRef]
PouliquenH.,
PinaultL.1994; Determination of oxolinic acid in seawater, marine sediment and Japanese oyster by high performance liquid chromatography. J Liq Chromatogr 17:929–945[CrossRef]
SamuelsenO. B.,
LunestadB. T.,
HusevagB.,
HollelandT.,
ErvikA.1992; Residues of oxolinic acid in wild fauna following medication in fish farms. Dis Aquat Org 12:111–119[CrossRef]
SantosY.,
Garcia-MarquezP. G.,
PereiraA.,
RiazaA.,
SilvaR.,
PazosF.2003; Evaluation of vaccines and vaccination strategies to protect cultured turbot against furunculosis. In 11th International Conference of the European Association of Fish Pathologists , Maltap– 219 (abstract
SchmidtA. S.,
BruunM. S.,
DalsgaardI.,
PedersenK.,
LarsenJ. L.2000; Occurrence of antimicrobial resistance in fish-pathogenic and environmental bacteria associated with four Danish rainbow trout farms. Appl Environ Microbiol 66:4908–4915[CrossRef]
SmithP.,
HineyM. P.,
SamuelsenO. B.1994; Bacterial resistance to antimicrobial agents used in fish farming: a critical evaluation of method and meaning. Annu Rev Fish Dis 4:273–313[CrossRef]
SpanggaardB.,
JorgensenF.,
GramL.,
HussH. H.1993; Antibiotic resistance in bacteria isolated from three freshwater fish farms and an unpolluted stream in Denmark. Aquaculture 115:195–207[CrossRef]
TsoumasA.,
AldermanD. J.,
RodgersC. J.1989; Aeromonas salmonicida : development of resistance to 4-quinolone antimicrobials. J Fish Dis 12:493–507[CrossRef]